Analysis of the role of immune deficiency in E2A-/- T cell lymphomagenesis
免疫缺陷在E2A-/- T细胞淋巴瘤发生中的作用分析
基本信息
- 批准号:8959799
- 负责人:
- 金额:$ 19.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-05-01 至 2017-04-30
- 项目状态:已结题
- 来源:
- 关键词:1 year oldAcute Lymphocytic LeukemiaAcute T Cell LeukemiaAddressAdultAffectAgeAmericanApplications GrantsBiological AssayBiological ModelsBone MarrowBone Marrow CellsCell CountCellsCellularityCharacteristicsChildChildhoodChimera organismChromosomal translocationDNA BindingDNA Sequence AlterationDataDefectDevelopmentDiseaseEngraftmentEtiologyGene ExpressionGenesGenetic TranscriptionHematopoieticHematopoietic SystemHigh PrevalenceHumanImmuneImmune systemIncidenceKidneyLYL1 geneLeadLobeLymphomaLymphomagenesisMalignant NeoplasmsModelingMolecular ProfilingMusMutationOncogenesPopulationPredispositionProteinsRNA SequencesRoleT-Cell DevelopmentT-Cell LymphomaT-Cell TransformationT-LymphocyteT-Lymphocyte SubsetsTAL1 geneTCF3 geneTestingTransplantationTreatment outcomeTumor Suppressor GenesTumor Suppressor Proteinscapsulecell typecombatcytokineinsightnovelpreventprogenitorprogramspublic health relevancereconstitutionresearch studythymocytetranscription factortranscriptome sequencingtreatment response
项目摘要
DESCRIPTION (provided by applicant): T lymphocyte lineage acute lymphoblastic leukemia is a malignancy that occurs in children and adults and is predicted to increase in incidence as the average age of the American population increases. While multiple oncogenes and tumor suppressors have been implicated in this disease greater than 60% of T-ALL cases have mutations that decreased the function of the E2A transcription factors. Moreover, mice lacking E2A proteins develop a T-ALL-like malignancy, a finding that led to the hypothesis that E2A proteins are tumor suppressors. In this grant application we will test an opposing hypothesis, that the immune deficiency created by loss of E2A proteins results in a loss of early thymocyte progenitor competition and that this loss of competition drives the development of T-ALL like disease. We will test our hypothesis by examining the ability of wild-type thymocyte progenitors to suppress transformation of E2A-deficient thymocytes and by testing whether the degree of immune deficiency in E2A-deficient mice is sufficient to promote transformation of WT cells using a novel model of thymic engraftment. We will also test the impact of increasing thymocyte progenitor competition on the gene expression program of E2A-deficient T cell progenitors to identify gene signatures that are regulated by immune deficiency as opposed to E2A-deficiency. Our experiments will provide significant insight into the mechanism of T cell transformation and may reveal that immune system decline is a precursor to T-ALL susceptibility.
描述(由申请人提供):T 淋巴细胞谱系急性淋巴细胞白血病是一种发生在儿童和成人中的恶性肿瘤,预计其发病率会随着美国人口平均年龄的增加而增加。虽然多种癌基因和肿瘤抑制基因与这种疾病有关,但超过 60% 的 T-ALL 病例存在降低 E2A 转录因子功能的突变。此外,缺乏E2A蛋白的小鼠会患上T-ALL样恶性肿瘤,这一发现引发了E2A蛋白是肿瘤抑制因子的假设。在本次拨款申请中,我们将测试一个相反的假设,即 E2A 蛋白缺失造成的免疫缺陷会导致早期胸腺细胞祖细胞竞争的丧失,而这种竞争的丧失会导致 T-ALL 样疾病的发展。我们将通过检查野生型胸腺细胞祖细胞抑制 E2A 缺陷型胸腺细胞转化的能力,并通过使用新型胸腺植入模型测试 E2A 缺陷型小鼠的免疫缺陷程度是否足以促进 WT 细胞的转化来检验我们的假设。我们还将测试增加胸腺细胞祖细胞竞争对 E2A 缺陷 T 细胞祖细胞基因表达程序的影响,以确定受免疫缺陷(而不是 E2A 缺陷)调节的基因特征。我们的实验将提供对 T 细胞转化机制的重要见解,并可能揭示免疫系统衰退是 T-ALL 易感性的先兆。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BARBARA L. KEE其他文献
BARBARA L. KEE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BARBARA L. KEE', 18)}}的其他基金
Investigating Helios as a regulator of natural killer cell effector maturation
研究 Helios 作为自然杀伤细胞效应成熟的调节剂
- 批准号:
10608673 - 财政年份:2023
- 资助金额:
$ 19.19万 - 项目类别:
Identification of BATF function and targets during NK cell activation
NK 细胞激活过程中 BATF 功能和靶标的鉴定
- 批准号:
10494220 - 财政年份:2021
- 资助金额:
$ 19.19万 - 项目类别:
Identification of BATF function and targets during NK cell activation
NK 细胞激活过程中 BATF 功能和靶标的鉴定
- 批准号:
10354363 - 财政年份:2021
- 资助金额:
$ 19.19万 - 项目类别:
Mechanisms of E protein transcription factor-dependent iNKT cell expansion and differentiation
E蛋白转录因子依赖性iNKT细胞扩增和分化的机制
- 批准号:
9242168 - 财政年份:2016
- 资助金额:
$ 19.19万 - 项目类别:
Mechanisms of E protein transcription factor-dependent iNKT cell expansion and differentiation
E蛋白转录因子依赖性iNKT细胞扩增和分化的机制
- 批准号:
10065488 - 财政年份:2016
- 资助金额:
$ 19.19万 - 项目类别:
Molecular Mechanisms of Invariant Natural Killer T Cell Differentiation
恒定自然杀伤T细胞分化的分子机制
- 批准号:
10627307 - 财政年份:2016
- 资助金额:
$ 19.19万 - 项目类别:
EZH2 in lymphoid lineage specification and commitment
EZH2 淋巴谱系规范和承诺
- 批准号:
8622415 - 财政年份:2014
- 资助金额:
$ 19.19万 - 项目类别:
Transcriptional Control of Natural Killer Cell Development
自然杀伤细胞发育的转录控制
- 批准号:
10540688 - 财政年份:2014
- 资助金额:
$ 19.19万 - 项目类别:
Regulation of Lymphocyte Development by HLH Proteins
HLH 蛋白对淋巴细胞发育的调节
- 批准号:
8791299 - 财政年份:2014
- 资助金额:
$ 19.19万 - 项目类别:
Regulation of Lymphocyte Development by HLH Proteins
HLH 蛋白对淋巴细胞发育的调节
- 批准号:
8638491 - 财政年份:2014
- 资助金额:
$ 19.19万 - 项目类别:
相似海外基金
Understanding of the onset and recurrence pattern of intractable acute lymphocytic leukemia based on clone analysis
基于克隆分析了解难治性急性淋巴细胞白血病的发病和复发模式
- 批准号:
20K08723 - 财政年份:2020
- 资助金额:
$ 19.19万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Novel Inhibitors of Multi-Drug-Resistant Mutants of BCR-ABL for the Treatment of Chronic Myelogenous Leukemia (CML) and Ph Positive Acute Lymphocytic Leukemia (ALL).
BCR-ABL 多重耐药突变体的新型抑制剂,用于治疗慢性粒细胞白血病 (CML) 和 Ph 阳性急性淋巴细胞白血病 (ALL)。
- 批准号:
9047400 - 财政年份:2015
- 资助金额:
$ 19.19万 - 项目类别:
The Role of Genetic Variants in Sensitivity to Methotrexate in Acute Lymphocytic Leukemia Survivors
遗传变异在急性淋巴细胞白血病幸存者对甲氨蝶呤敏感性中的作用
- 批准号:
319114 - 财政年份:2014
- 资助金额:
$ 19.19万 - 项目类别:
Fellowship Programs
Targeting the Bone Marrow Microenvironment In Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的骨髓微环境
- 批准号:
8595788 - 财政年份:2013
- 资助金额:
$ 19.19万 - 项目类别:
Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的缺氧微环境
- 批准号:
8023518 - 财政年份:2011
- 资助金额:
$ 19.19万 - 项目类别:
Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的缺氧微环境
- 批准号:
8404025 - 财政年份:2011
- 资助金额:
$ 19.19万 - 项目类别:
Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的缺氧微环境
- 批准号:
8220724 - 财政年份:2011
- 资助金额:
$ 19.19万 - 项目类别:
Targeting hypoxic microenvironment in Acute Lymphocytic Leukemia
针对急性淋巴细胞白血病的缺氧微环境
- 批准号:
8599754 - 财政年份:2011
- 资助金额:
$ 19.19万 - 项目类别:
INSULIN RESISTANCE IN CHILDREN WITH ACUTE LYMPHOCYTIC LEUKEMIA UNDERGOING INDUCT
正在接受治疗的急性淋巴细胞白血病儿童的胰岛素抵抗
- 批准号:
8356701 - 财政年份:2010
- 资助金额:
$ 19.19万 - 项目类别:
INSULIN RESISTANCE IN CHILDREN WITH ACUTE LYMPHOCYTIC LEUKEMIA UNDERGOING INDUCT
正在接受治疗的急性淋巴细胞白血病儿童的胰岛素抵抗
- 批准号:
8166720 - 财政年份:2009
- 资助金额:
$ 19.19万 - 项目类别:














{{item.name}}会员




